Should Value Investors Buy Cardinal Health (CAH) Stock?

Zacks has identified Cardinal Health (CAH) as a compelling value stock, assigning it a Zacks Rank #2 (Buy) and an 'A' Value grade. This assessment is underpinned by CAH's favorable valuation metrics, including a PEG ratio of 1.47 (below the industry average of 1.61) and a P/CF ratio of 15.58 (below the industry average of 15.72), suggesting the stock is currently undervalued.

Analysis

Cardinal Health (CAH) is presented as a compelling value opportunity based on the Zacks Rank system, which assigned it a #2 (Buy) rating and an 'A' grade for Value. This positive outlook is supported by key valuation metrics that suggest the company is undervalued relative to its peers and its growth prospects. Specifically, CAH's Price/Earnings to Growth (PEG) ratio stands at 1.47, which is below the industry average of 1.61, indicating a more attractive price for its expected earnings growth. The stock's current PEG is also near its 12-month median of 1.50. Furthermore, the Price-to-Cash-Flow (P/CF) ratio of 15.58 is slightly favorable compared to the industry average of 15.72, signaling a solid cash flow outlook. The combination of a strong earnings outlook, as implied by the Zacks Buy rating, and these favorable valuation metrics underpins the argument that CAH currently represents an attractive investment for value-oriented investors.

Key Decisions for Investors

• Value-focused investors should consider Cardinal Health for their portfolios, given its 'A' grade for Value and key metrics like PEG and P/CF that are below industry averages.
• Since the positive thesis is heavily reliant on the Zacks Rank #2 (Buy), which emphasizes earnings estimates, investors should closely monitor upcoming earnings reports and any analyst estimate revisions for CAH.
• While the valuation is attractive relative to the industry, investors should note that the current PEG and P/CF ratios are near their 12-month medians, suggesting that establishing a position may not represent a cyclical low point for the stock.